Systemic inflammation in chronic obstructive pulmonary disease: May adipose tissue play a role? Review of the literature and future perspectives

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Tkacova, Ruzena ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ADIPOSE TISSUE; BODY COMPOSITION; BRONCHUS OBSTRUCTION; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXIA; INFLAMMATION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; WEIGHT GAIN; ANOXIA; IMMUNOLOGY; LITERATURE; METABOLISM; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ANOXIA; BODY COMPOSITION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; OBESITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REVIEW LITERATURE AS TOPIC;

EID: 77952487032     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/585989     Document Type: Review

References (118)

1. Pauwels R. A., Buist A. S., Calverley P. M. A., Jenkins C. R., Hurd S. S., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary American Journal of Respiratory and Critical Care Medicine 2001 163 5 1256 1276
2. Rabe K. F., Hurd S., Anzueto A., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary American Journal of Respiratory and Critical Care Medicine 2007 176 6 532 555
3. Barnes P. J., Celli B. R., Systemic manifestations and comorbidities of COPD European Respiratory Journal 2009 33 5 1165 1185
4. Wouters E. F. M., Local and systemic inflammation in chronic obstructive pulmonary disease Proceedings of the American Thoracic Society 2005 2 1 26 33
5. Fabbri L. M., Rabe K. F., Multiple chronic diseases Proceedings of a European Respiratory Society Research Seminar February 2007 Rome, Italy
6. McGarvey L. P., John M., Anderson J. A., Zvarich M., Wise R. A., Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee Thorax 2007 62 5 411 415
7. Bruunsgaard H., Pedersen B. K., Age-related inflammatory cytokines and disease Immunology and Allergy Clinics of North America 2003 23 1 15 39
8. Sin D. D., Paul Man S. F., Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 2003 107 11 1514 1519
9. Steuten L. M. G., Creutzberg E. C., Vrijhoef H. J. M., Wouters E. F., COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care Primary Care Respiratory Journal 2006 15 2 84 91
10. Franssen F. M. E., ODonnell D. E., Goossens G. H., Blaak E. E., Schols A. M. W. J., Obesity and the lung: 5. Obesity and COPD Thorax 2008 63 12 1110 1117
11. Fabbri L. M., Rabe K. F., From COPD to chronic systemic inflammatory syndrome? The Lancet 2007 370 9589 797 799
12. Sevenoaks M. J., Stockley R. A., Chronic obstructive pulmonary disease, inflammation and co-morbidity: a common inflammatory phenotype? Respiratory Research 2006 7, article 70
13. Mannino D. M., Watt G., Hole D., The natural history of chronic obstructive pulmonary disease European Respiratory Journal 2006 27 3 627 643
14. Dentener M. A., Creutzberg E. C., Schols A. M., Systematic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations Thorax 2001 56 721 726
15. Mannino D. M., Ford E. S., Redd S. C., Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination American Journal of Medicine 2003 114 9 758 762
16. Schols A. M. W. J., Slangen J., Volovics L., Wouters E. F. M., Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 1998 157 6 1791 1797
17. Landbo C., Prescott E., Lange P., Vestbo J., Almdal T. P., Prognostic value of nutritional status in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 1999 160 6 1856 1861 (Pubitemid 30004687)
18. Prescott E., Almdal T., Mikkelsen K. L., Tofteng C. L., Vestbo J., Lange P., Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study European Respiratory Journal 2002 20 3 539 544
19. Koehler F., Doehner W., Hoernig S., Witt C., Anker S. D., John M., Anorexia in chronic obstructive pulmonary disease: association to cachexia and hormonal derangement International Journal of Cardiology 2007 119 1 83 89
20. Petersen A. M. W., Penkowa M., Iversen M., Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease Lung 2007 185 3 161 171
21. Margretardottir O. B., Thorleifsson S. J., Gudmundsson G., Hypertension, systemic inflammation and body weight in relation to lung function impairment: an epidemiological study Journal of Chronic Obstructive Pulmonary Disease 2009 6 4 250 255
22. Connors A. F. Jr., Dawson N. V., Thomas C., Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to understand prognoses and preferences for outcomes and risks of treatments) American Journal of Respiratory and Critical Care Medicine 1996 154 4 959 967
23. Kolsum U., Roy K., Starkey C., The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year Journal of Chronic Obstructive Pulmonary Disease 2009 4 1 149 156
24. Watson L., Vonk J. M., Lfdahl C. G., Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study Respiratory Medicine 2006 100 4 746 753
25. Kessler R., Faller M., Fourgaut G., Mennecier B., Weitzenblum E., Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 1999 159 1 158 164
26. Vitacca M., Clini E., Porta R., Foglio K., Ambrosino N., Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation European Respiratory Journal 1996 9 7 1487 1493
27. Justo D., Lachmi S., Saar N., C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia European Journal of Internal Medicine 2009 20 5 518 521
28. de Torres J. P., Cordoba-Lanus E., Lopez-Aguillar C., C-reactive protein levels and clinically important predictive outcomes in stable COPD patients European Respiratory Journal 2006 27 5 902 907
29. Man S. F. P., Connett J. E., Anthonisen N. R., Wise R. A., Tashkin D. P., Sin D. D., C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease Thorax 2006 61 10 849 853
30. Vernooy J. H., Kckaycan M., Jacobs J. A., Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum American Journal of Respiratory and Critical Care Medicine 2002 166 9 1218 1224
31. Zeng M., Wen Y., Liu L.-Y., Wang H., Guan K.-P., Huang X., Role of TNF-alpha, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease Respiration 2009 78 4 399 403
32. Chung K. F., Adcock I. M., Multifaceted mechanisms in COPD: inflammation, imunity, and tissue repair and destruction European Respiratory Journal 2008 31 1334 1356
33. Van Eeden S. F., Sin D. D., Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease Respiration 2008 75 2 224 238
34. Kim V., Rogers T. J., Criner G. J., New concepts in the pathobiology of chronic obstructive pulmonary disease Proceedings of the American Thoracic Society 2008 5 4 478 485 (Pubitemid 351669174)
35. Kennedy S. M., Elwood R. K., Wiggs B. J. R., Increased airway mucosal permeability of smokers. Relationship to airway reactivity American Review of Respiratory Disease 1984 129 1 143 148
36. Wollmer P., Evander E., Biphasic pulmonary clearance of 99mTc-DTPA in smokers Clinical Physiology 1994 14 5 547 559
37. Olivera D. S., Boggs S. E., Beenhouwer C., Aden J., Knall C., Cellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitro Inhalation Toxicology 2007 19 1 13 22
38. Schmekel B., Borgstrom L., Wollmer P., Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers Thorax 1991 46 4 225 228
39. Fujita M., Shannon J. M., Ouchi H., Voelker D. R., Nakanishi Y., Mason R. J., Serum surfactant protein D is increased in acute and chronic inflammation in mice Cytokine 2005 31 1 25 33
40. Tamagawa E., Suda K., Wei Y., Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation Innate Immunity 2009 15 4 251 258
41. Chou S.-H., Chen Y.-W., Chuang H.-Y., Kao E.-L., Huang M.-F., Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease Journal of Clinical Pharmacy and Therapeutics 2006 31 4 363 368
42. Man S. F. P., Xuekui Z., Vessey R., The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study Therapeutic Advances in Respiratory Disease 2009 3 2 73 80
43. Antoniu S. A., Inhaled corticosteroids in COPD: systemic effects of a local therapy? Expert Opinion on Pharmacotherapy 2008 9 3271 3273
44. Fontana L., Eagon J. C., Trujillo M. E., Scherer P. E., Klein S., Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 2007 56 4 1010 1013
45. Poulain M., Doucet M., Drapeau V., Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease Chronic Respiratory Disease 2008 5 1 35 41
46. Marquis K., Maltais F., Duguay V., The metabolic syndrome in patients with chronic obstructive pulmonary disease Journal of Cardiopulmonary Rehabilitation 2005 25 4 226 232 (Pubitemid 41153761)
47. Vestbo J., Prescott E., Almdal T., Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study American Journal of Respiratory and Critical Care Medicine 2006 173 1 79 83
48. Engelen M. P. K. J., Schols A. M. W. J., Lamers R. J. S., Wouters E. F. M., Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease Clinical Nutrition 1999 18 5 275 280
49. Sergi G., Coin A., Marin S., Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease Respiratory Medicine 2006 100 11 1918 1924
50. Liu X., Ji Y., Chen J., Li S., Luo F., Circulating visfatin in chronic obstructive pulmonary disease Nutrition 2009 25 4 373 378
51. Poulain M., Doucet M., Major G. C., The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies Canadian Medical Association Journal 2006 174 9 1293 1299
52. Leone N., Courbon D., Thomas F., Lung function impairment and metabolic syndrome the critical role of abdominal obesity American Journal of Respiratory and Critical Care Medicine 2009 179 6 509 516
53. Lam K.-B. H., Jordan R. E., Jiang C. Q., Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study European Respiratory Journal 2010 35 2 317 323
54. Guerra S., Sherrill D. L., Bobadilla A., Martinez F. D., Barbee R. A., The relation of body mass index to asthma, chronic bronchitis, and emphysema Chest 2002 122 4 1256 1263
55. Schokker D. F., Visscher T. L. S., Nooyens A. C. J., Van Baak M. A., Seidell J. C., Prevalence of overweight and obesity in the Netherlands Obesity Reviews 2007 8 2 101 108
56. ten Hacken N. H. T., Physical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease? Proceedings of the American Thoracic Society 2009 6 8 663 667
57. Watz H., Waschki B., Kirsten A., The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity Chest 2009 136 4 1039 1046
58. Garcia-Aymerich J., Lange P., Benet M., Schnohr P., Ant J. M., Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study American Journal of Respiratory and Critical Care Medicine 2007 175 5 458 463
59. Bolton C. E., Evans M., Ionescu A. A., Insulin resistance and inflammation: a further systemic complication of COPD Journal of Chronic Obstructive Pulmonary Disease 2007 4 2 121 126
60. Koehler F., Doehner W., Hoernig S., Witt C., Anker S. D., John M., Anorexia in chronic obstructive pulmonary disease: association to cachexia and hormonal derangement International Journal of Cardiology 2007 119 1 83 89
61. Landbo C., Prescott E., Lange P., Vestbo J., Almdal T. P., Prognostic value of nutritional status in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 1999 160 6 1856 1861 (Pubitemid 30004687)
62. Vestbo J., Prescott E., Almdal T., Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study American Journal of Respiratory and Critical Care Medicine 2006 173 1 79 83
63. Tisdale M. J., Mechanisms of cancer cachexia Physiological Reviews 2009 89 2 381 410
64. Mijn-de-la-Torre A., Recent insights on chronic heart failure, cachexia and nutrition Current Opinion in Clinical Nutrition and Metabolic Care 2009 12 3 251 257
65. Fleet M., Osman F., Komaragiri R., Fritz A., Raj D. S. C., Protein catabolism in advanced renal disease: role of cytokines Clinical Nephrology 2008 70 2 91 100
66. Gelato M., McNurlan M., Freedland E., Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment Clinical Therapeutics 2007 29 11 2269 2288
67. Trayhurn P., Beattie J. H., Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ Proceedings of the Nutrition Society 2001 60 329 339
68. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556
69. Trayhurn P., Wood I. S., Adipokines: inflammation and the pleiotropic role of white adipose tissue British Journal of Nutrition 2004 92 3 347 355
70. Mohamed-Ali V., Goodrick S., Rawesh A., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo Journal of Clinical Endocrinology and Metabolism 1997 82 12 4196 4200
71. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance Journal of Clinical Investigation 1995 95 5 2409 2415
72. Warne J. P., Tumour necrosis factor alpha: a key regulator of adipose tissue mass Journal of Endocrinology 2003 177 3 351 355
73. Ruan H., Hacohen N., Golub T. R., Van Parijs L., Lodish H. F., Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory Diabetes 2002 51 5 1319 1336
74. Mohamed-Ali V., Flower L., Sethi J., Beta-adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies Journal of Clinical Endocrinology and Metabolism 2001 86 5864 5869
75. Kern P. A., Ranganathan S., Li C., Wood L., Ranganathan G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance American Journal of Physiology 2001 280 5 E745 E751
76. Greenberg A. S., Nordan R. P., McIntosh J., Calvo J. C., Scow R. O., Jablons D., Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia Cancer Research 1992 52 15 4113 4116
77. Strassmann G., Fong M., Kenney J. S., Jacob C. O., Evidence for the involvement of interleukin 6 in experimental cancer cachexia Journal of Clinical Investigation 1992 89 5 1681 1684
78. Bruun J. M., Pedersen S. B., Kristensen K., Richelsen B., Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss Obesity Research 2002 10 6 499 506
79. Zumbach M. S., Boehme M. W. J., Wahl P., Stremmel W., Ziegler R., Nawroth P. P., Tumor necrosis factor increases serum leptin levels in humans Journal of Clinical Endocrinology and Metabolism 1997 82 12 4080 4082
80. Loffreda S., Yang S. Q., Lin H. Z., Leptin regulates proinflammatory immune responses FASEB Journal 1998 12 1 57 65
81. Haluzik M., Matoulek M., Svacina S, The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females Endocrine Research 2001 27 1-2 251 260
82. Sin D. D., Man S. F. P., Impaired lung function and serum leptin in men and women with normal body weight: a population based study Thorax 2003 58 8 695 698
83. Creutzberg E. C., Schols A. M., Weling-Scheepers C. A., Buurman W. A., Wouters E. F. M., Characterization of nonresponse to high caloric oral nutritional therapy m depleted patients with chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 2000 161 3 745 752
84. Yamauchi T., Kamon J., Waki H., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nature Medicine 2001 7 8 941 946
85. Bruun J. M., Lihn A. S., Verdich C., Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans American Journal of Physiology 2003 285 3 E527 E533
86. Krommidas G., Kostikas K., Papatheodorou G., Plasma lepin and adiponectin in COPD exacerbations: associations with inflammatorz biomarkers Respiratory Medicine 2010 104 1 40 41
87. Skurk T., Alberti-Huber C., Herder C., Hauner H., Relationship between adipocyte size and adipokine expression and secretion Journal of Clinical Endocrinology and Metabolism 2007 92 3 1023 1033
88. Bastard J.-P., Jardel C., Bruckert E., Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss Journal of Clinical Endocrinology and Metabolism 2000 85 9 3338 3342
89. Maachi M., Pieroni L., Bruckert E., Systemic low-grade inflammation is related to both circulating and adipose tissue TNF, leptin and IL-6 levels in obese women International Journal of Obesity 2004 28 8 993 997
90. Alessi M.-C., Bastelica D., Morange P., Plasminogen activator inhibitor 1, transforming growth factor-b1, and BMI are closely associated in human adipose tissue during morbid obesity Diabetes 2000 49 8 1374 1380
91. Summers L. K. M., Samra J. S., Humphreys S. M., Morris R. J., Frayn K. N., Subcutaneous abdominal adipose tissue blood now: variation within and between subjects and relationship to obesity Clinical Science 1996 91 6 679 683
92. Chen B., Lam K. S. L., Wang Y., Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes Biochemical and Biophysical Research Communications 2006 341 2 549 556
93. Hosogai N., Fukuhara A., Oshima K., Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation Diabetes 2007 56 4 901 911
94. Wenger R. H., Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression FASEB Journal 2002 16 10 1151 1162
95. Charo I. F., Taubman M. B., Chemokines in the pathogenesis of vascular disease Circulation Research 2004 95 9 858 866
96. Shoelson S. E., Lee J., Yuan M., Inflammation and the IKK /I B/NF-κB axis in obesity-and diet-induced insulin resistance International Journal of Obesity 2003 27 supplement 3 S49 S52
97. Semenza G. L., HIF-1 and mechanisms of hypoxia sensing Current Opinion in Cell Biology 2001 13 2 167 171
98. Semenza G. L., Targeting HIF-1 for cancer therapy Nature Reviews Cancer 2003 3 10 721 732
99. Rocha S., Gene regulation under low oxygen: holding your breath for transcription Trends in Biochemical Sciences 2007 32 8 389 397
100. Trayhurn P., Wang B., Wood I. S., Hypoxia and the endocrine and signalling role of white adipose tissue Archives of Physiology and Biochemistry 2008 114 4 267 276
101. Takabatake N., Nakamura H., Abe S., The relationship between chronic hypoxemia and activation of the tumor necrosis factor-aplha system in patients with chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 2000 161 4 1179 1184
102. Supinski G. S., Callahan L. A., Free radical-mediated skeletal muscle dysfunction in inflammatory conditions Journal of Applied Physiology 2007 102 5 2056 2063
103. Tkacova R., Kluchova Z., Joppa P., Petrasova D., Molcanyiova A., Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD Respiratory Medicine 2007 101 8 1670 1676
104. Lvy P., Bonsignore M. R., Eckel J., Sleep, sleep-disordered breathing and metabolic consequences European Respiratory Journal 2009 34 1 243 260
105. Barcelo A., Barbe F., Llompart E., Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea American Journal of Medicine 2004 117 2 118 121
106. Ryan S., Taylor C. T., McNicholas W. T., Predictors of elevated nuclear factor-B-dependent genes in obstructive sleep apnea syndrome American Journal of Respiratory and Critical Care Medicine 2006 174 7 824 830
107. Dorkova Z., Petrasova D., Molcanyiova A., Popovnakova M., Tkacova R., Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome Chest 2008 134 4 686 692
108. Li J., Grigoryev D. N., Ye S. Q., Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice Journal of Applied Physiology 2005 99 5 1643 1648
109. Iiyori N., Alonso L. C., Li J., Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity American Journal of Respiratory and Critical Care Medicine 2007 175 8 851 857
110. Li J., Savransky V., Nanayakkara A., Smith P. L., ODonnell C. P., Polotsky V. Y., Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia Journal of Applied Physiology 2007 102 2 557 563
111. Yokoe T., Alonso L. C., Romano L. C., Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic-cell replication in mice Journal of Physiology 2008 586 3 899 911
112. Bruno A., Chanez P., Chiappara G., Does leptin play a cytokine-like role within the airways of COPD patients? European Respiratory Journal 2005 26 3 398 405
113. Miller M., Cho J. Y., Pham A., Ramsdell J., Broide D. H., Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease Journal of Immunology 2009 182 1 684 691
114. Vernooy J. H. J., Drummen N. E. A., van Suylen R. J., Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers Thorax 2009 64 1 26 32
115. Hansel N. N., Gao L., Rafaels N. M., Leptin receptor polymorphisms and lung function decline in COPD European Respiratory Journal 2009 34 1 103 110
116. Shore S. A., Terry R. D., Flynt L., Xu A., Hug C., Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice Journal of Allergy and Clinical Immunology 2006 118 2 389 395
117. Sorensen G. L., Hjelmborg J. V. B., Leth-Larsen R., Surfactant protein D of the innate immune defence is inversely associated with human obesity and SP-D deficiency infers increased body weight in mice Scandinavian Journal of Immunology 2006 64 6 633 638
118. Srensen G. L., Hjelmborg J. V.B., Kyvik K. O., Genetic and environmental influences of surfactant protein D serum levels American Journal of Physiology 2006 290 5 L1010 L1017